SomnoMed delivered its 100,000th SomnoDent sleep apnea appliance case since the inception of the company.
The 100,000th patient suffered from moderate obstructive sleep apnea with an AHI of 15. When asked why the SomnoDent sleep apnea appliance was chosen for this patient, the treating dentist said, “She had excellent dentition and a minimal jaw opening, which meant we needed to use a thin, comfortable appliance without restriction in movement. She tended to have some concerns regarding comfort and limited opening.” The patient was provided treatment options such as CPAP therapy and oral appliance therapy, and chose the SomnoDent.
SomnoMed recently announced changes in its top management structure and a significant expansion of its medical capabilities in the United States, which will include the addition of a chief medical officer, the formation of a medical advisory board, and the addition of several staff in the marketing and sales area with a medical background.
“After building the foundation of our global business in the last 5 years, we are now entering the next stage in the development of our business, which will see SomnoMed establishing itself in the mainstream of the medical device industry treating patients with sleep-related breathing disorders. Our rate of growth has been very impressive over the last 5 years, and we believe that these developments will allow us to substantially increase our growth over the next 5 years,” said Dr Peter Neustadt, executive chairman of SomnoMed Limited.
